Skip to main content
Top
Published in: Journal of Orthopaedic Surgery and Research 1/2017

Open Access 01-12-2017 | Research article

Tranexamic acid reduces hidden blood loss in the treatment of intertrochanteric fractures with PFNA: a single-center randomized controlled trial

Authors: Jinlai Lei, Binfei Zhang, Yuxuan Cong, Yan Zhuang, Xing Wei, Yahui Fu, Wei Wei, Pengfei Wang, Shiming Wen, Hai Huang, Hu Wang, Shuang Han, Shuguang Liu, Kun Zhang

Published in: Journal of Orthopaedic Surgery and Research | Issue 1/2017

Login to get access

Abstract

Background

Hidden blood loss is a major concern for patients undergoing hip surgery for intertrochanteric fracture. The objective of this study was to investigate whether tranexamic acid (TXA) could reduce postoperative hidden blood loss in patients undergoing hip surgery for intertrochanteric fracture.

Methods

A total of 77 patients with intertrochanteric fracture were enrolled in this randomized controlled study. Patients received either 200 mL (1 g) of TXA (n = 37) or normal-saline (NS) (n = 40) i.v. before hip surgery using proximal femoral nail anti-rotation (PFNA). Hemoglobin and hematocrit levels were measured preoperatively and postoperatively at day 1 and 3. Visible and hidden blood loss volumes were calculated at postoperative day 3.

Results

On postoperative day 3, the transfusion rate was significantly lower in the TXA group compared to the NS group, although mean hemoglobin and hematocrit levels were not significantly different between the two groups. However, the estimated hidden blood loss volume (210.09 ± 202.14 mL vs. 359.35 ± 290.12 mL; P < 0.05) and total blood loss volume (279.35 ± 209.11 mL vs. 417.89 ± 289.56 mL; P < 0.05) were significantly less in the TXA group compared to the NS group, respectively.

Conclusion

TXA significantly reduced postoperative hidden blood loss in patients with intertrochanteric fracture who underwent PFNA.
(Registration number: ChiCTR-INR-16008134).
Literature
1.
go back to reference Peeters CM, Visser E, Van de Ree CL, Gosens T, Den Oudsten BL, De Vries J. Quality of life after hip fracture in the elderly: a systematic literature review. Injury. 2016;47(7):1369–82.CrossRefPubMed Peeters CM, Visser E, Van de Ree CL, Gosens T, Den Oudsten BL, De Vries J. Quality of life after hip fracture in the elderly: a systematic literature review. Injury. 2016;47(7):1369–82.CrossRefPubMed
2.
go back to reference Cooper C, Cole Z, Holroyd C, Earl S, Harvey N, Dennison E, Melton L, Cummings S, Kanis J. Epidemiology ICWGoF: secular trends in the incidence of hip and other osteoporotic fractures. Osteoporos Int. 2011;22(5):1277.CrossRefPubMedPubMedCentral Cooper C, Cole Z, Holroyd C, Earl S, Harvey N, Dennison E, Melton L, Cummings S, Kanis J. Epidemiology ICWGoF: secular trends in the incidence of hip and other osteoporotic fractures. Osteoporos Int. 2011;22(5):1277.CrossRefPubMedPubMedCentral
4.
go back to reference Carvajal-Pedrosa C, Gómez-Sánchez RC, Hernández-Cortés P. Comparison of outcomes of Intertrochanteric fracture fixation using percutaneous compression plate between stable and unstable fractures in the elderly. J Orthop Trauma. 2016;30(6):e201–e06.CrossRefPubMed Carvajal-Pedrosa C, Gómez-Sánchez RC, Hernández-Cortés P. Comparison of outcomes of Intertrochanteric fracture fixation using percutaneous compression plate between stable and unstable fractures in the elderly. J Orthop Trauma. 2016;30(6):e201–e06.CrossRefPubMed
5.
go back to reference Dhamangaonkar AC, Joshi D, Goregaonkar AB, Tawari AA. Proximal femoral locking plate versus dynamic hip screw for unstable intertrochanteric femoral fractures. J Orthop Surg. 2013;21(3):317–22.CrossRef Dhamangaonkar AC, Joshi D, Goregaonkar AB, Tawari AA. Proximal femoral locking plate versus dynamic hip screw for unstable intertrochanteric femoral fractures. J Orthop Surg. 2013;21(3):317–22.CrossRef
6.
go back to reference Foss NB, Kehlet H. Hidden blood loss after surgery for hip fracture. Bone Joint J. 2006;88(8):1053–9.CrossRef Foss NB, Kehlet H. Hidden blood loss after surgery for hip fracture. Bone Joint J. 2006;88(8):1053–9.CrossRef
7.
go back to reference Kannus P, Parkkari J, Sievänen H, Heinonen A, Vuori I, Järvinen M. Epidemiology of hip fractures. Bone. 1996;18(1):S57–63.CrossRef Kannus P, Parkkari J, Sievänen H, Heinonen A, Vuori I, Järvinen M. Epidemiology of hip fractures. Bone. 1996;18(1):S57–63.CrossRef
8.
go back to reference Sharrock N. Fractured femur in the elderly: intensive perioperative care is warranted. Br J Anaesth. 2000;84(2):139.CrossRefPubMed Sharrock N. Fractured femur in the elderly: intensive perioperative care is warranted. Br J Anaesth. 2000;84(2):139.CrossRefPubMed
9.
go back to reference Swain D, Nightingale P, Patel J. Blood transfusion requirements in femoral neck fracture. Injury. 2000;31(1):7–10.CrossRefPubMed Swain D, Nightingale P, Patel J. Blood transfusion requirements in femoral neck fracture. Injury. 2000;31(1):7–10.CrossRefPubMed
10.
go back to reference Yu W, Zhang X, Wu R, Zhu X, Hu J, Xu Y, Yi J, Liu Y. The visible and hidden blood loss of Asia proximal femoral nail anti-rotation and dynamic hip screw in the treatment of intertrochanteric fractures of elderly high-risk patients: a retrospective comparative study with a minimum 3 years of follow-up. BMC Musculoskelet Disord. 2016;17(1):269.CrossRefPubMedPubMedCentral Yu W, Zhang X, Wu R, Zhu X, Hu J, Xu Y, Yi J, Liu Y. The visible and hidden blood loss of Asia proximal femoral nail anti-rotation and dynamic hip screw in the treatment of intertrochanteric fractures of elderly high-risk patients: a retrospective comparative study with a minimum 3 years of follow-up. BMC Musculoskelet Disord. 2016;17(1):269.CrossRefPubMedPubMedCentral
11.
go back to reference Wassilew G, Perka C, Janz V, Krämer M, Renner L. Tranexamic acid reduces the blood loss and blood transfusion requirements following peri-acetabular osteotomy. Bone Joint J. 2015;97(12):1604–7.CrossRefPubMed Wassilew G, Perka C, Janz V, Krämer M, Renner L. Tranexamic acid reduces the blood loss and blood transfusion requirements following peri-acetabular osteotomy. Bone Joint J. 2015;97(12):1604–7.CrossRefPubMed
12.
go back to reference Wang H, Shen B, Zeng Y. Blood loss and transfusion after topical tranexamic acid administration in primary total knee arthroplasty. Orthopedics. 2015;38(11):e1007–e16.CrossRefPubMed Wang H, Shen B, Zeng Y. Blood loss and transfusion after topical tranexamic acid administration in primary total knee arthroplasty. Orthopedics. 2015;38(11):e1007–e16.CrossRefPubMed
13.
go back to reference Tengberg P, Foss N, Palm H, Kallemose T, Troelsen A. Tranexamic acid reduces blood loss in patients with extracapsular fractures of the hip. Bone Joint J. 2016;98(6):747–53.CrossRefPubMed Tengberg P, Foss N, Palm H, Kallemose T, Troelsen A. Tranexamic acid reduces blood loss in patients with extracapsular fractures of the hip. Bone Joint J. 2016;98(6):747–53.CrossRefPubMed
14.
go back to reference Poeran J, Rasul R, Suzuki S, Danninger T, Mazumdar M, Opperer M, Boettner F, Memtsoudis SG. Tranexamic acid use and postoperative outcomes in patients undergoing total hip or knee arthroplasty in the United States: retrospective analysis of effectiveness and safety. BMJ. 2014;349(aug12 8):g4829.CrossRefPubMedPubMedCentral Poeran J, Rasul R, Suzuki S, Danninger T, Mazumdar M, Opperer M, Boettner F, Memtsoudis SG. Tranexamic acid use and postoperative outcomes in patients undergoing total hip or knee arthroplasty in the United States: retrospective analysis of effectiveness and safety. BMJ. 2014;349(aug12 8):g4829.CrossRefPubMedPubMedCentral
15.
go back to reference Perel P, Ker K, Morales Uribe CH, Roberts I. Tranexamic acid for reducing mortality in emergency and urgent surgery. Cochrane Database Syst Rev. 2013;1(1):CD010245. Perel P, Ker K, Morales Uribe CH, Roberts I. Tranexamic acid for reducing mortality in emergency and urgent surgery. Cochrane Database Syst Rev. 2013;1(1):CD010245.
16.
go back to reference Gillespie R, Shishani Y, Joseph S, Streit JJ, Gobezie R. Neer award 2015: a randomized, prospective evaluation on the effectiveness of tranexamic acid in reducing blood loss after total shoulder arthroplasty. J Shoulder Elb Surg. 2015;24(11):1679–84.CrossRef Gillespie R, Shishani Y, Joseph S, Streit JJ, Gobezie R. Neer award 2015: a randomized, prospective evaluation on the effectiveness of tranexamic acid in reducing blood loss after total shoulder arthroplasty. J Shoulder Elb Surg. 2015;24(11):1679–84.CrossRef
17.
go back to reference Farrow LS, Smith TO, Ashcroft GP, Myint PK. A systematic review of tranexamic acid in hip fracture surgery. Br J Clin Pharmacol. 2016;82(6):1458–70.CrossRefPubMed Farrow LS, Smith TO, Ashcroft GP, Myint PK. A systematic review of tranexamic acid in hip fracture surgery. Br J Clin Pharmacol. 2016;82(6):1458–70.CrossRefPubMed
18.
go back to reference Smith G, Tsang J, Molyneux S, White T. The hidden blood loss after hip fracture. Injury. 2011;42(2):133–5.CrossRefPubMed Smith G, Tsang J, Molyneux S, White T. The hidden blood loss after hip fracture. Injury. 2011;42(2):133–5.CrossRefPubMed
19.
go back to reference Good L, Peterson E, Lisander B. Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement. BJA Br J Anaesth. 2003;90(5):596.CrossRefPubMed Good L, Peterson E, Lisander B. Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement. BJA Br J Anaesth. 2003;90(5):596.CrossRefPubMed
20.
go back to reference Chen X, Zhu X, Yang S, Lin W, Wang L. Tranexamic acid treatment decreases hidden blood loss in total knee arthroplasty. Am J Ther. 2016;23(6):e1397–e405.CrossRef Chen X, Zhu X, Yang S, Lin W, Wang L. Tranexamic acid treatment decreases hidden blood loss in total knee arthroplasty. Am J Ther. 2016;23(6):e1397–e405.CrossRef
21.
go back to reference Seol Y-J, Seon J-K, Lee S-H, Jin C, Prakash J, Park Y-J, Song E-K. Effect of tranexamic acid on blood loss and blood transfusion reduction after Total knee Arthroplasty. Knee Surg Relat Res. 2016;28(3):188.CrossRefPubMedPubMedCentral Seol Y-J, Seon J-K, Lee S-H, Jin C, Prakash J, Park Y-J, Song E-K. Effect of tranexamic acid on blood loss and blood transfusion reduction after Total knee Arthroplasty. Knee Surg Relat Res. 2016;28(3):188.CrossRefPubMedPubMedCentral
22.
go back to reference Xie J, Ma J, Yao H, Yue C, Pei F. Multiple boluses of intravenous tranexamic acid to reduce hidden blood loss after primary total knee arthroplasty without tourniquet: a randomized clinical trial. J Arthroplast. 2016;31(11):2458–64.CrossRef Xie J, Ma J, Yao H, Yue C, Pei F. Multiple boluses of intravenous tranexamic acid to reduce hidden blood loss after primary total knee arthroplasty without tourniquet: a randomized clinical trial. J Arthroplast. 2016;31(11):2458–64.CrossRef
23.
go back to reference Drakos A, Raoulis V, Karatzios K, Doxariotis N, Kontogeorgakos V, Malizos K, Varitimidis SE. Efficacy of local administration of tranexamic acid for blood salvage in patients undergoing Intertrochanteric fracture surgery. J Orthop Trauma. 2016;30(8):409–14.CrossRefPubMed Drakos A, Raoulis V, Karatzios K, Doxariotis N, Kontogeorgakos V, Malizos K, Varitimidis SE. Efficacy of local administration of tranexamic acid for blood salvage in patients undergoing Intertrochanteric fracture surgery. J Orthop Trauma. 2016;30(8):409–14.CrossRefPubMed
24.
go back to reference Marsh JL, Slongo TF, Agel J, Broderick JS, Creevey W, Decoster TA, Prokuski L, Sirkin MS, Ziran B, Henley B. Fracture and dislocation classification compendium - 2007: orthopaedic trauma association classification, database and outcomes committee. J Orthop Trauma. 2007;21(10 Suppl):1–133.CrossRef Marsh JL, Slongo TF, Agel J, Broderick JS, Creevey W, Decoster TA, Prokuski L, Sirkin MS, Ziran B, Henley B. Fracture and dislocation classification compendium - 2007: orthopaedic trauma association classification, database and outcomes committee. J Orthop Trauma. 2007;21(10 Suppl):1–133.CrossRef
25.
go back to reference Foster CG. International ethical guidelines for biomedical research involving human subjects. J Med Ethics. 2002;10(182):17. Foster CG. International ethical guidelines for biomedical research involving human subjects. J Med Ethics. 2002;10(182):17.
26.
go back to reference Gross JB. Estimating allowable blood loss corrected for dilution. J Am Soc Anesthesiol. 1983;58(3):277–80.CrossRef Gross JB. Estimating allowable blood loss corrected for dilution. J Am Soc Anesthesiol. 1983;58(3):277–80.CrossRef
27.
go back to reference Meunier A, Petersson A, Good L, Berlin G. Validation of a haemoglobin dilution method for estimation of blood loss. Vox Sang. 2008;95(2):120–4.CrossRefPubMed Meunier A, Petersson A, Good L, Berlin G. Validation of a haemoglobin dilution method for estimation of blood loss. Vox Sang. 2008;95(2):120–4.CrossRefPubMed
28.
go back to reference Nadler SB, Hidalgo JH, Bloch T. Prediction of blood volume in normal human adults. Surgery. 1962;51(2):224–32.PubMed Nadler SB, Hidalgo JH, Bloch T. Prediction of blood volume in normal human adults. Surgery. 1962;51(2):224–32.PubMed
29.
go back to reference Benoni G, Fredin H. Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty. Bone Joint J. 1996;78(3):434–40. Benoni G, Fredin H. Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty. Bone Joint J. 1996;78(3):434–40.
30.
go back to reference Syrovets T, Lunov O, Simmet T. Plasmin as a proinflammatory cell activator. J Leukoc Biol. 2012;92(3):509–19.CrossRefPubMed Syrovets T, Lunov O, Simmet T. Plasmin as a proinflammatory cell activator. J Leukoc Biol. 2012;92(3):509–19.CrossRefPubMed
31.
go back to reference Jimenez JJ, Iribarren JL, Lorente L, Rodriguez JM, Hernandez D, Nassar I, Perez R, Brouard M, Milena A, Martinez R. Tranexamic acid attenuates inflammatory response in cardiopulmonary bypass surgery through blockade of fibrinolysis: a case control study followed by a randomized double-blind controlled trial. Crit Care. 2007;11(6):R117.CrossRefPubMedPubMedCentral Jimenez JJ, Iribarren JL, Lorente L, Rodriguez JM, Hernandez D, Nassar I, Perez R, Brouard M, Milena A, Martinez R. Tranexamic acid attenuates inflammatory response in cardiopulmonary bypass surgery through blockade of fibrinolysis: a case control study followed by a randomized double-blind controlled trial. Crit Care. 2007;11(6):R117.CrossRefPubMedPubMedCentral
32.
go back to reference Hsia T-Y, McQuinn TC, Mukherjee R, Deardorff RL, Squires JE, Stroud RE, Crawford FA, Bradley SM, Reeves ST, Spinale FG. Effects of aprotinin or tranexamic acid on proteolytic/cytokine profiles in infants after cardiac surgery. Ann Thorac Surg. 2010;89(6):1843–52.CrossRefPubMedPubMedCentral Hsia T-Y, McQuinn TC, Mukherjee R, Deardorff RL, Squires JE, Stroud RE, Crawford FA, Bradley SM, Reeves ST, Spinale FG. Effects of aprotinin or tranexamic acid on proteolytic/cytokine profiles in infants after cardiac surgery. Ann Thorac Surg. 2010;89(6):1843–52.CrossRefPubMedPubMedCentral
33.
go back to reference Wingerter SA, Keith AD, Schoenecker PL, Baca GR, Clohisy JC. Does tranexamic acid reduce blood loss and transfusion requirements associated with the periacetabular osteotomy? Clin Orthop Relat Res. 2015;473(8):2639–43.CrossRefPubMedPubMedCentral Wingerter SA, Keith AD, Schoenecker PL, Baca GR, Clohisy JC. Does tranexamic acid reduce blood loss and transfusion requirements associated with the periacetabular osteotomy? Clin Orthop Relat Res. 2015;473(8):2639–43.CrossRefPubMedPubMedCentral
34.
go back to reference Duncan CM, Gillette BP, Jacob AK, Sierra RJ, Sanchez-Sotelo J, Smith HM. Venous thromboembolism and mortality associated with tranexamic acid use during total hip and knee arthroplasty. J Arthroplast. 2015;30(2):272–6.CrossRef Duncan CM, Gillette BP, Jacob AK, Sierra RJ, Sanchez-Sotelo J, Smith HM. Venous thromboembolism and mortality associated with tranexamic acid use during total hip and knee arthroplasty. J Arthroplast. 2015;30(2):272–6.CrossRef
35.
go back to reference Yang Z-G, Chen W-P, Wu L-D. Effectiveness and safety of tranexamic acid in reducing blood loss in total knee arthroplasty: a meta-analysis. J Bone Joint Surg Am. 2012;94(13):1153–9.CrossRefPubMed Yang Z-G, Chen W-P, Wu L-D. Effectiveness and safety of tranexamic acid in reducing blood loss in total knee arthroplasty: a meta-analysis. J Bone Joint Surg Am. 2012;94(13):1153–9.CrossRefPubMed
36.
go back to reference Liu Y, Meng F, Yang G, Kong L, Shen Y. Comparison of intra-articular versus intravenous application of tranexamic acid in total knee arthroplasty: a meta-analysis of randomized controlled trials. Arch Med Sci: AMS. 2017;13(3):533.CrossRefPubMedPubMedCentral Liu Y, Meng F, Yang G, Kong L, Shen Y. Comparison of intra-articular versus intravenous application of tranexamic acid in total knee arthroplasty: a meta-analysis of randomized controlled trials. Arch Med Sci: AMS. 2017;13(3):533.CrossRefPubMedPubMedCentral
Metadata
Title
Tranexamic acid reduces hidden blood loss in the treatment of intertrochanteric fractures with PFNA: a single-center randomized controlled trial
Authors
Jinlai Lei
Binfei Zhang
Yuxuan Cong
Yan Zhuang
Xing Wei
Yahui Fu
Wei Wei
Pengfei Wang
Shiming Wen
Hai Huang
Hu Wang
Shuang Han
Shuguang Liu
Kun Zhang
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Journal of Orthopaedic Surgery and Research / Issue 1/2017
Electronic ISSN: 1749-799X
DOI
https://doi.org/10.1186/s13018-017-0625-9

Other articles of this Issue 1/2017

Journal of Orthopaedic Surgery and Research 1/2017 Go to the issue